Bone-marrowTIDE PLUS forte: A European study on the effectiveness of anemia treatment.
In 2017, specialists from the Regenerative Medicine and Nutritional Medicine Department of the European Scientific Society at the Academy of Natural Sciences (Hanover) conducted a study to evaluate the effectiveness of the multi-component peptide complex "Bone-marrowTIDE PLUS forte" in patients with iron deficiency anemia.
Patients' complaints of general weakness, rapid fatigue, sweating, dizziness, tinnitus, dry skin, and brittle and splitting nails were analyzed. The study included general clinical blood and urine tests, biochemical blood tests, esophagogastroduodenoscopy (EGD), and stool tests for occult blood.
Patients who participated in the study.
The study involved 26 patients (aged 52–77 years), who were divided into two groups:
- The main group consisted of 13 patients who additionally received "Bone-marrowTIDE PLUS forte".
- The control group consisted of 13 patients treated only with standard methods.
Twelve patients had previously used iron supplements or been treated with other methods, but the effectiveness of these treatments had not been thoroughly investigated.
Bone-marrowTIDE PLUS usage schedule
The main group of patients received the multicomponent peptide bioregulator "Bone-marrowTIDE PLUS forte" at a dose of 2 capsules per day for 30–45 days , depending on the severity of the pathological process.
The patients in the control group received only standard treatment without additional bioregulators.
Research results
The results showed that patients who used "Bone-marrowTIDE PLUS forte" in conjunction with standard treatment achieved significantly better results:
- Hemoglobin levels increased by an average of 24.3 ± 6.7 g/L .
- The indicators for microcytosis, anisocytosis, and poikilocytosis have improved.
- Non-hemoglobin iron and ferritin levels increased.
- Clinical symptoms (weakness, fatigue, dizziness) regressed faster – on average within 3.1 ± 1.4 days .
According to EGDS results, erosive processes in the stomach were detected in 2 main and 2 control group patients. During a follow-up examination after 20–24 days, no erosions were found.
Long-term effects
The study revealed that longer use of Bone-marrowTIDE PLUS (40–45 days) provided a more stable and pronounced effect.
In half of the patients who used the complex for more than 30 days, biochemical parameters normalized , and clinical symptoms disappeared faster than in the control group.
Safety and tolerance
Throughout the entire study, it was observed that "Bone-marrowTIDE PLUS forte" had no side effects . No complications, changes in heart or liver function, or risk of dependence were detected .
Summary – Bone-marrowTIDE PLUS as an innovative solution for the treatment of anemia
This European expert study confirmed that Bone-marrowTIDE PLUS forte can be an effective supplement to standard treatment for iron deficiency anemia. Regular use not only improved blood parameters but also reduced clinical symptoms more quickly, giving patients more energy, better well-being, and a higher quality of life.
Source of information: https://myrealway.com/bone-marrowtide-peptides-blood-formation
